Page results
-
The Macmillan Support and Information Service celebrates its developments and achievements since opening ten years ago.
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
The Secretary of State for Health and Social Care, The Rt. Hon. Sajid Javid MP visited the National Hospital for Neurology and Neurosurgery (NHNN), earlier this week (Wednesday 4 May 2022).
-
Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly less time in hospital, concludes a trial led by UCLH, UCL and the University of Sheffield.
-
Matthew Fielden and Lillyanne Tran volunteer in the cognitive disorders outpatients’ clinic at the National Hospital for Neurology and Neurosurgery.
-
Advice on preventing the spread of flu and other respiratory viruses, to keep UCLH patients safe.
-
This page tells you about the procedure known as varicocele (pronounced VARI-CO-SEAL) embolisation.
-
This page explains what a gastroscopy is and what it enolves.
File results
-
FOI/2024/0338 - Ophthalmology outpatient activity 2022, 2023 and 2024
-
FOI/2024/0337 - IVF clinical unit/ embryology laboratory
-
FOI/2024/0333 - Elective treatment wait over 65 weeks
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0291 - Private patient income 2020-2023